camptothecin has been researched along with Experimental Hepatoma in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (20.93) | 18.7374 |
1990's | 8 (18.60) | 18.2507 |
2000's | 3 (6.98) | 29.6817 |
2010's | 20 (46.51) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Cai, B; Huang, M; Jiang, J; Li, Z; Luo, M; Wang, L; Wu, L | 1 |
Liang, GB; Ma, XL; Su, D; Wei, JH; Xin, M; Yang, CH; Zhang, Y | 1 |
Cai, K; Li, B; Li, K; Lin, C; Liu, G; Lu, L; Luo, Z; Xia, Z | 1 |
Huang, S; Li, M; Nie, X; Ren, D; Wang, Y; Wu, X; Yu, X | 1 |
Chen, M; Chen, Z; Li, X; Liu, W; Wang, T; Xie, S; Zhao, L | 1 |
He, W; Jiang, Y; Li, Q; Li, Z; Luan, Y; Zhang, D | 1 |
Du, FF; Hu, ZY; Li, C; Li, XX; Niu, W; Sun, Y; Wang, FQ; Xu, F; Yang, JL | 1 |
Delaunay, F; Dulong, S; Dumitru, M; Filipski, E; Guettier, C; Lévi, F; Li, XM; Mohammad-Djafari, A; Mteyrek, A; Scaglione, F; Siffroi-Fernandez, S | 1 |
Adams, R; Becker, M; Bhargava, A; Ellinghaus, P; Hoffmann, J; Kahmann, N; Müller, T; Rosenthal, A; Schmieder, R; Scholz, A; Thierauch, KH; Wilhelm, SM; Zopf, D | 1 |
Hu, HH; Song, HX | 1 |
Gilbert, CW; Hukuoka, Y; Kichikawa, K; Masada, T; Nishiofuku, H; Obayashi, C; Sato, T; Takano, M; Tanaka, T | 1 |
Hayashi, A; Higashi, Y; Hori, Y; Kishimoto, K; Maeda, N; Morii, E; Ohashi, F; Osuga, K; Tanaka, K; Tomiyama, N | 1 |
Ghegediban, SH; Laurent, A; Maeda, N; Namur, J; Osuga, K; Paci, A; Pascale, F; Reb, P; Seck, A; Sterba, M; Verret, V; Wassef, M | 1 |
Caine, M; Dreher, MR; Dunn, A; Fowers, KD; Grey, D; Hall, B; Johnson, CG; Lewis, AL; O'Byrne, V; Sharma, KV; Tang, Y; Wood, BJ | 1 |
Fukuoka, Y; Kichikawa, K; Masada, T; Matsushima, S; Nishiofuku, H; Ohbayashi, C; Sato, T; Sho, M; Takano, M; Tanaka, T; Tatsumoto, S; Yamato, I; Yasuda, S | 1 |
Li, J; Oupický, D; Ping, Q; Qiao, H; Su, Z; Sun, M; Xie, Y; Zhang, C | 1 |
Gu, J; Han, HB; Hu, MH; Li, JY; Wang, Y; Xie, Y; Xing, BC; Xu, XL; Xu, ZL; Zhang, ZQ; Zhao, W | 1 |
Gong, T; Liu, J; Ren, K; Shi, SJ; Sun, X; Wei, W; Zhang, XN; Zhang, ZR; Zhao, D | 1 |
Kenmotsu, H; Kinoshita, T; Koga, Y; Kuroda, J; Matsumura, Y; Ohkohchi, N; Takahashi, A; Yasunaga, M | 1 |
Feng, G; Liang, B; Liang, H; Qian, J; Wang, Y; Zhao, H; Zheng, C | 1 |
Auperin, A; Bize, P; de Baere, T; Denys, A; Deschamps, F; Drouard-Troalen, L; Paci, A; Pascale, F; Rao, PP; Seck, A; Teriitheau, C | 1 |
Fu, H; Grieves, JL; La Perle, KM; McCarty, DM; Rosas, LE; Zaraspe, K | 1 |
Jia, G; Li, X; Luo, X; Song, H; Xu, G; Yan, S; Yang, S | 1 |
Evans, JF; Kargman, S; Kelly, CR; Kwong, E; Lam, EC; Luk, P; Wolfe, MM; Yao, M; Zheng, Y | 1 |
Aoyagi, Y; Enomoto, T; Nakajima, M; Noguchi, M; Oda, T; Ohkohchi, N; Satake, M; Sugiura, S | 1 |
Ling, YH; Xu, B; Yu, WJ | 2 |
Han, JX; Shen, ZM; Xu, B; Yang, JL | 1 |
Lo, KW; Miller, EE; Tsou, KC; Xu, B | 1 |
Ling, YH; Xu, B | 2 |
Chan, J; Roffler, SR; Yeh, MY | 1 |
Brumfield, A; Dookeran, KA; Rubin, JT | 1 |
Fidler, IJ; Killion, JJ; Kumar, R; Kuniyasu, H; Shinohara, H | 1 |
Hashimoto, A; Matsuura, T; Murakami, K; Saiki, I; Sakukawa, R; Sano, M; Yamada, Y; Yonekura, K | 1 |
Qing, C; Xu, B; Zhang, XW | 1 |
Bucci, F; Capocasa, F; Carenini, N; Carminati, P; De Cesare, M; Merlini, L; Pace, S; Penco, S; Perego, P; Pisano, C; Pratesi, G; Tinelli, S; Vesci, L; Zunino, F | 1 |
Shu, RS; Wang, ZW; Xu, B | 1 |
Liu, J; Xu, B; Yang, SL | 1 |
Wu, XJ | 2 |
Ling, YH; Xu, B; Zhao, CS | 1 |
43 other study(ies) available for camptothecin and Experimental Hepatoma
Article | Year |
---|---|
Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Liver Neoplasms, Experimental; Matrines; Mice; Molecular Docking Simulation; Molecular Structure; Pyrroles; Quinolizines; Structure-Activity Relationship | 2018 |
Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms, Experimental; Mice; Molecular Structure; Naphthalimides; Structure-Activity Relationship | 2020 |
Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Proliferation; Cell Survival; Cells, Cultured; Drug Screening Assays, Antitumor; Female; Hep G2 Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Nanoparticles; Optical Imaging; Oxidation-Reduction; Particle Size; Prodrugs; Surface Properties; Surface-Active Agents | 2020 |
Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Peptide Fragments; Surface Properties; tat Gene Products, Human Immunodeficiency Virus; Tumor Cells, Cultured | 2020 |
Acid-Labile Degradation of Injectable Fiber Fragments to Release Bioreducible Micelles for Targeted Cancer Therapy.
Topics: Animals; Apoptosis; Camptothecin; Cell Aggregation; Cell Proliferation; Hep G2 Cells; Humans; Hyaluronic Acid; Liver Neoplasms, Experimental; Mice; Micelles; Polyesters; Stilbenes | 2018 |
A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
Topics: Animals; Camptothecin; Drug Delivery Systems; Hep G2 Cells; Humans; Hyperthermia, Induced; Indoles; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Phototherapy; Prodrugs | 2019 |
Pharmacokinetic evaluation of the anticancer prodrug simmitecan in different experimental animals.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carboxylesterase; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Injections, Intravenous; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Microsomes, Liver; Prodrugs; Rats; Rats, Sprague-Dawley; Species Specificity; Tissue Distribution; Xenograft Model Antitumor Assays | 2013 |
A circadian clock transcription model for the personalization of cancer chronotherapy.
Topics: Animals; ARNTL Transcription Factors; Camptothecin; Chronotherapy; Circadian Clocks; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Irinotecan; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Models, Biological; Nuclear Receptor Subfamily 1, Group D, Member 1; Period Circadian Proteins; Precision Medicine; RNA, Messenger; Topoisomerase I Inhibitors | 2013 |
Regorafenib (BAY 73-4506): antitumor and antimetastatic activities in preclinical models of colorectal cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Growth Processes; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Phenylurea Compounds; Pyridines; Random Allocation; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3; Xenograft Model Antitumor Assays | 2014 |
[Efficacy of treatment with siRNA targeting Bcl-2 in combination with HCPT against transplanted H₂₂ hepatoma in mice].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Cycle; Drug Synergism; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-bcl-2; Random Allocation; RNA, Messenger; RNA, Small Interfering; Transfection; Tumor Burden | 2013 |
Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model.
Topics: Alkaline Phosphatase; Animals; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Camptothecin; Chemistry, Pharmaceutical; Chemoembolization, Therapeutic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Irinotecan; Liver Neoplasms, Experimental; Microspheres; Necrosis; Particle Size; Rabbits | 2014 |
In vivo evaluation of irinotecan-loaded QuadraSphere microspheres for use in chemoembolization of VX2 liver tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Chemoembolization, Therapeutic; Disease Models, Animal; Female; Irinotecan; Liver Neoplasms, Experimental; Microspheres; Rabbits; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
Topics: Activation, Metabolic; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chemoembolization, Therapeutic; Drug Carriers; Gene Expression Regulation, Neoplastic; Hepatic Artery; Injections, Intra-Arterial; Irinotecan; Liver Neoplasms, Experimental; Male; Microspheres; Necrosis; Particle Size; Rabbits; Tissue Distribution | 2015 |
DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Catheters; Doxorubicin; Drug Carriers; Irinotecan; Liver Neoplasms, Experimental; Rabbits; X-Ray Microtomography | 2016 |
Intraarterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rabbit Liver Tumor Model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Area Under Curve; Camptothecin; Drug Carriers; Drug Compounding; Female; Femoral Vein; Hepatic Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Irinotecan; Liver Neoplasms, Experimental; Micelles; Nanoparticles; Necrosis; Rabbits; Tissue Distribution | 2017 |
Arginine-Modified Nanostructured Lipid Carriers with Charge-Reversal and pH-Sensitive Membranolytic Properties for Anticancer Drug Delivery.
Topics: Animals; Antineoplastic Agents; Arginine; Camptothecin; Chitosan; Drug Carriers; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms, Experimental; Male; Mice; Nanostructures; Rats; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2017 |
The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Camptothecin; Carcinoma, Hepatocellular; Cell Adhesion; Cisplatin; Comparative Genomic Hybridization; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, SCID; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oligonucleotide Array Sequence Analysis; Paclitaxel; Poly(ADP-ribose) Polymerases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Phospholipids; Tissue Distribution | 2010 |
Detailed distribution of NK012, an SN-38-incorporating micelle, in the liver and its potent antitumor effects in mice bearing liver metastases.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Proliferation; Chromatography, High Pressure Liquid; Colonic Neoplasms; Disease Models, Animal; Humans; Irinotecan; Kaplan-Meier Estimate; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.
Topics: Alanine Transaminase; Angiography, Digital Subtraction; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Aspartate Aminotransferases; Camptothecin; Carcinoma, Hepatocellular; Cell Proliferation; Chemoembolization, Therapeutic; Embolization, Therapeutic; Hepatic Artery; In Situ Nick-End Labeling; Iodized Oil; Ki-67 Antigen; Liver Function Tests; Liver Neoplasms, Experimental; Liver Regeneration; Magnetic Resonance Imaging; Necrosis; Polyvinyl Alcohol; Rabbits; Time Factors; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2011 |
Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor model.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Bilirubin; Camptothecin; Chemoembolization, Therapeutic; Drug Delivery Systems; Infusions, Intra-Arterial; Infusions, Intravenous; Irinotecan; Liver Neoplasms, Experimental; Rabbits; Statistics, Nonparametric | 2012 |
Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.
Topics: Animals; Base Sequence; Camptothecin; Carcinoma, Hepatocellular; Dependovirus; DNA Damage; Female; Fibroblast Growth Factor 10; Fibroblast Growth Factor 3; Genetic Vectors; Genome, Viral; Hepatectomy; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C3H; Mice, SCID; Molecular Sequence Data; Mutagenesis, Insertional; Proto-Oncogene Proteins p21(ras); Proto-Oncogenes; SOS1 Protein; Transcriptional Activation; Virus Integration | 2012 |
Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzaldehydes; Camptothecin; Carcinoma, Hepatocellular; Electrochemistry; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Lactates; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Molecular Weight; Polyethylene Glycols; Survival Rate; Tumor Microenvironment | 2012 |
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Camptothecin; Cell Division; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytoskeletal Proteins; Dinoprostone; Drug Synergism; Endothelial Growth Factors; Fluorouracil; Intercellular Signaling Peptides and Proteins; Interleukin-10; Interleukin-12; Irinotecan; Isoenzymes; Lactones; Liver Neoplasms, Experimental; Lymphokines; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Prostaglandin-Endoperoxide Synthases; Sulfones; Trans-Activators; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Disease Models, Animal; Gemcitabine; Humans; Injections, Intravenous; Irinotecan; Liver Neoplasms, Experimental; Mice; Mice, Nude; Microspheres; Neoplasm Transplantation; Pancreatic Neoplasms; Portal Vein; Rats; Rats, Nude; Transplantation, Heterologous | 2006 |
[Effect of 10-hydroxycamptothecin on nuclear RNA polymerase activity in hepatoma cells in mice].
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Nucleus; DNA-Directed RNA Polymerases; Liver Neoplasms, Experimental; Mice | 1984 |
[Effects of 10-hydroxycamptothecin on cAMP and cGMP levels in hepatoma and liver tissue of mice (author's transl)].
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cyclic AMP; Cyclic GMP; DNA, Neoplasm; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred ICR | 1981 |
[Effect of 10-hydroxycamptothecin on adenylate cyclase activity in murine hepatoma cells].
Topics: Adenylyl Cyclases; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cyclic AMP; Dopamine; Liver Neoplasms, Experimental; Mice | 1982 |
Anti-tumor effect of (S)-10-hydroxycamptothecin on mouse hepatoma BW7756 and its possible mode of action.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; Flow Cytometry; Liver Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation | 1981 |
Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; DNA, Neoplasm; Histones; Liver Neoplasms, Experimental; Mice; Phosphorylation; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1993 |
Potentiation of radioimmunotherapy by inhibition of topoisomerase I.
Topics: Animals; Antibodies, Monoclonal; Camptothecin; Combined Modality Therapy; Female; Gamma Rays; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Rats; Rats, Sprague-Dawley; Topoisomerase I Inhibitors | 1994 |
A comparison of locoregional depot and systemic preparations of 9-aminocamptothecin for treatment of liver metastases in a rat tumor model: superior antitumor activity of sustained-release preparation.
Topics: Animals; Antineoplastic Agents; Camptothecin; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Ethiodized Oil; Liver Neoplasms, Experimental; Rats; Rats, Inbred F344 | 1997 |
Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Administration Schedule; Drug Synergism; Intestinal Diseases; Irinotecan; Lipopeptides; Lipoproteins; Liver Neoplasms, Experimental; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C | 1998 |
4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Benzoates; Body Weight; Camptothecin; Carcinoma, Hepatocellular; Fluorouracil; Humans; Irinotecan; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Molecular Structure; Neoplasm Invasiveness; Proto-Oncogene Proteins c-met; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; Specific Pathogen-Free Organisms; Survival Rate; Trimethylsilyl Compounds; Tumor Cells, Cultured | 1998 |
Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Cycle; Cell Division; Cell Nucleus; Cell Survival; DNA Fragmentation; DNA, Neoplasm; Electrophoresis, Agar Gel; Humans; Kinetics; Liver Neoplasms, Experimental; Microscopy, Fluorescence; Tumor Cells, Cultured | 1999 |
Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
[Influence of sodium camptothecin on the concomitant tumor immunity in mice (author's transl)].
Topics: Animals; Camptothecin; Liver Neoplasms, Experimental; Mice; Neoplasm Transplantation; Sarcoma, Experimental; Transplantation, Isogeneic | 1979 |
[The influence of 10-hydroxycamptothecin on the ultrastructure of ascitic hepatoma cells in mice (author's transl)].
Topics: Animals; Camptothecin; Carcinoma, Ehrlich Tumor; Liver Neoplasms, Experimental; Mice | 1979 |
Effects of lycobetaine on chromatin structure and activity of murine hepatoma cells.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Chromatin; Dactinomycin; DNA Damage; DNA, Neoplasm; Harringtonines; Homoharringtonine; Indolizines; Liver Neoplasms, Experimental; Mice; Oncogenes; Time Factors; Tumor Cells, Cultured | 1990 |
[An experimental study of the basic properties of drug microspheres and target treatment of rats with liver tumor].
Topics: Animals; Camptothecin; Delayed-Action Preparations; Embolization, Therapeutic; Female; Infusions, Intra-Arterial; Liver Neoplasms, Experimental; Male; Microspheres; Rats; Rats, Inbred Strains | 1990 |
[The effect of drug-microsphere embolization of hepatic artery on normal liver and experimental hepatic tumor in rats].
Topics: Animals; Camptothecin; Capsules; Embolization, Therapeutic; Female; Hepatic Artery; Liver Neoplasms, Experimental; Male; Microspheres; Radiography; Rats; Rats, Inbred Strains | 1989 |
[Effects of 10-hydroxycamptothecin on chromatin protein synthesis in murine hepatoma cells].
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Chromatin; Chromosomal Proteins, Non-Histone; Histones; Liver Neoplasms, Experimental; Mice | 1986 |
The effect of hydroxycamptothecin in the activity of RNA and DNA polymerases prepared from murine hepatoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Nucleus; DNA Polymerase I; DNA Polymerase II; DNA Replication; DNA-Directed RNA Polymerases; In Vitro Techniques; Liver Neoplasms, Experimental; Mice; Nucleic Acid Synthesis Inhibitors | 1985 |